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The purpose of this study was to evaluate the effect of pharmacist
intervention on the prevention and solution of drug therapy-
problems (DTP), Body Mass Index (BMI), and blood pressure
control in elderly outpatients with hypertension. The instruments
were applied to 30 elderly outpatients assisted at the pharmacy of
a primary health care unit in Ribeirão Preto (SP), Brazil. The group
of patients received follow-up during a period of 12 months. It
was observed that Pharmaceutical Care intervention optimized
the medication use; reduced symptoms caused by drug therapy
and improved the elderly patients’ health conditions. The
Pharmaceutical Care intervention influenced the care given to
elderly people as well as the achievement of positive health
outcomes. After this study, the researcher gave training about
practice of Pharmaceutical Care to 38 dispensing pharmacists
from the Public Health-System of Ribeirão Preto. Nowadays, these
pharmacists are perpetuating the practice introduced in the region.
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Hypertension is a common chronic health condition
among older people and is the most important risk factor for
all subtypes of vascular disease and death. According
WHO (2003), the hypertension afflicts approximately 600
million people around the world, including the majority of
elderly, and imposes enormous burdens through associated
cardiovascular diseases. In Brazil, cardiovascular diseases
remain the leading cause of death reaching 32% of all cau-
ses of mortality (Muxfeldt et al., 2004).
Although the benefits of antihypertensive
medications are clearly established, only 60% of
hypertensive patients are currently treated, and only 34%
are adequately controlled (Goodley et al., 2003). Moreover,
the high incidence of drug-therapy problems (DTP) in
elderly patients with hypertension has been reported in
literature (Rollason, Vogt, 2003; Garção, Cabrita, 2002).
The economic impact of DTP is enormous in USA,
totaling US$104 billions annually and rivaling the cost of
diseases common in the older population (Erwin, 1999).
These preventable negative patient outcomes and their
associated costs have caught the attention of patients,
healthcare professionals, and governmental agencies (Kohn
et al., 1999)
In Brazil, most elderly patients with hypertension are
using prescribed drugs by the Public Health Care System
(SUS) to control the disease. Despite such therapy, most of
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patients have inadequate blood pressure (BP) control, with
increased risk of associated cardiovascular morbidity and
mortality (Zaitune et al., 2006; Muxfeldt et al., 2004). This
uncontrolled hypertension is commonly associated with
non-adherence to drug therapy and/or lack of access to
health care (Chobanian, 2001). Therefore, changes in SUS
are necessary to improve the care of these patients.
In recent years, the shift of health care toward an
ambulatory has increased the demand for quality outpatient
clinical pharmacy services. Pharmacists have been
encouraged to provide Pharmaceutical Care to identify,
prevent, and resolve DTP and mediate dialogue with
patients and physicians, monitoring and alerting them to
uncontrolled BP values and optimizing the
pharmacotherapy (Lyra Jr. et al., 2007; Lyra Jr. et al.,
2006). Pharmaceutical care has been defined as the
responsible provision of drug therapy for the purpose of
achieving defined outcomes that improve a patient’s quality
of life (Hepler, Strand, 1990).
In other countries, previous research have shown that
pharmacist involvement in the ambulatorial care of
hypertensive patients improves BP control (Lee et al.,
2006; Zillich et al., 2005; Vivian, 2002; Mehos et al.,
2000). Although, primary care units are the entrance of
SUS, it almost does not have studies published about
Pharmaceutical Care practice in Brazil (Lyra Jr. et al.,
2007; Souza et al., 2007; Castro et al., 2006; Lyra Jr. et al.,
2005; Oliveira et al., 2005). Thus, the purpose of this study
was to evaluate the effect of pharmacist intervention on the
prevention and solution of drug therapy-problems (DTP),
Body Mass Index (BMI), and blood pressure control in
elderly outpatients with hypertension.
METHODS
A longitudinal, prospective study (semi-experimen-
tal) was conducted at a primary health care unit (PHCU) in
Ribeirão Preto (SP), Brazil, from August, 2003 to July,
2004. This setting was chosen because 300 of the patients
had hypertension, and the center’s health care providers
identified 40% (120) non-adherence as a primary reason for
poor outcomes to treatment. At PHCU, the outpatients were
attended to by four physicians, two dispensing pharmacists,
and one research pharmacist.
Patients
During a week period, all hypertensive outpatients
who came to the ambulatory care pharmacy of PHCU to
receive their medication were identified as potential
candidates for the study. Patients were eligible to
participate if they met three or more of the following criteria
(Koecheler et al., 1989): five or more drugs in their
regimen, twelve or more doses per day, a medication
regimen that had changed four or more times in the past
year, three or more co-morbidities, a history of medication
non-compliance, and the presence of at least one drug that
requires therapeutic monitoring (Box 1).
Exclusion criteria were: stage 3 hypertension
(systolic e•180 mm Hg and/or diastolic pressure e•110 mm
Hg based on JNC-VI criteria), an identified secondary cau-
se of hypertension, such as chronic renal disease,
pheochromocytoma, Cushing’s syndrome, or had missed
more than three appointments during the program.
The nature of the study was described to the patients,
and informed consent forms were signed by those eligible
and interested in participating.
Pharmaceutical Care program
Patients were scheduled to visit the research
pharmacist once per month at PHCU during the period of
a year. The research pharmacist (DPLJ) interviewed each
patient for forty minutes, using a checklist with essential
issues such as socio-demographic variables, health
situation, and drug therapy (Currie et al., 2003). The
Pharmaceutical Care interview program included: active
listening, review of health situation and drug history,
identification of needs and problems, assessment, care plan,
documentation, and intervention.
Pharmaceutical Care intervention
During the Pharmaceutical Care program,
interventions aimed at personal transformation and the
awakening of patients’ “critical consciousness”, and were
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divided into: health education and drug therapy (Freire,
1983). Such transformation is attributed to three key
consciousness-raising experiences: relating to and
reflecting on experience; personal exploration and problem
solving; and taking thoughtful action. These steps provide
a framework for Freire’s participatory social orientation
approach to the design of effective educational strategies in
health. While originally applied to the teaching of basic
literacy skills to adults in Brazil, it has been used
internationally in health education (Roter et al., 2001;
Freire, 1983).
Educative intervention consisted of: counseling
concerning chronic health conditions (nature, causes, and
treatment) and changes in lifestyle, identification of signs
and symptoms caused by medication (effectiveness and
safety), and encouragement of patients to participate
actively in the proposed drug therapy.
The research pharmacist evaluated patients
individually to identify actual and potential DTP. DTP is
any undesirable event experienced by a patient which
involves, or is suspected to involve, drug therapy and that
interferes with achieving the desired goals of therapy
(Cipolle et al., 2004). It was divided in terms of need,
effectiveness, and safety (Comité del Consenso, 2002). All
data was recorded on an individual form and updated
monthly, thus forming a database. The drug therapy
intervention also consisted of: assessment of drug history
(current and past medication) and drug-taking ability,
solution and prevention of DTP (actual and potential),
clarification questions regarding orders, use, and storage of
medicines and implementation of adherence-improving
strategies.
Statistical analysis
The paired t test was used to measure differences in
mean of DTP, Body Mass Index (BMI) and systolic and
diastolic BP between baseline and end of this study. All
analyses used SPSS (version 12, SPSS Inc., Chicago, IL).
A significance level of 0.05 was adopted for all statistical
tests. All results were validated by means of Wilcoxon’s
Rank-sum test.
RESULTS AND DISCUSSION
Socio-demographic and health situation profile
The mean age of patients was 66 ± 5 years, 20 of
whom were women (n=30). Twenty one (71%) of the patients
had low literacy. In Brazil, individuals with reduced
education levels are approximately 5 times as likely to have
health problems (Rosa et al., 2003). One of most dramatic
problems identified is the extremely poor level of patient
knowledge and understanding (Naves, Silver, 2005). In this
situation, the educational interventions could contribute to
awareness development and to the exchange of experiences,
replacing dominant and informative actions that were distant
from the patients’ reality (Roter et al., 2001). Empowering
experiences foster the competence and confidence necessary
for personal transformation and the realization of “critical
consciousness”.
There was a predominance of retirees/pensioners 19
(63%) and housewives 7 (27%) in this study. According to
Rosa et al. (2003), retirees and housewives are almost 8
times as likely to present morbidities. The mean chronic
health conditions per patient individual corresponded to 3.5
± 1.5. In this study, patients presented at least two chronic
health conditions (mainly hypertension, diabetes mellitus
and hypercholesterolemy); as a consequence they had to be
treated by five different specialist physicians, to take
multiple medications and to made difficult comprehension
about drug therapy. Hypertension, diabetes, and asthma,
major causes of morbidity and hospitalization, showed an
important therapeutic drug gap (Naves, Silver, 2005). In
the literature, it has been demonstrated that the number of
drugs prescribed increases with the number of physicians
seen (Lyra Jr. et al., 2004; Rollason, Vogt, 2003).
Drug therapy profile
During the study period were consumed 250
medicines, the mean 8.5 ± 4 drugs per elderly, the most of
them (81%) prescribed by physicians. Twenty outpatients
received more than five different drugs prescribed. In
Brazil, the true prevalence of the inappropriateness and
redundancy among prescriptions is underestimated
(Nóbrega et al., 2006; Gimenes et al., 2006; Lyra Jr. et al.,
2004).
Evaluation of Pharmaceutical Care intervention
92 DTP were identified during the study, 3.0 ± 1.5
problems per patient. Twenty one patients showed a mean
of 2.6 actual DTP and 0.5 potential DTP. 29% of them were
detected by own patients, mainly a higher incidence of
problems in the of the Safety category (64%). These DTP
had been caused by: diuretics (12 [19%]), analgesics (10
[16%]), calcium channel blockers (9 [14%]) and
angiotensin-converting-enzyme (ACE) inhibitors (8
[13%]). The high medication consumption and high
incidence of DTP (mainly in the of the Safety category)
showed that the medication acted as harmful agent to the
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elderly health and caused symptoms such as: orthostatic
hypotension, gastritis, dizziness and cramps.
In this study, 590 interventions were performed and
documented, for both drug therapy (214) and health
education (376). These interventions were equally
distributed among the different chronic health conditions
that the patients suffered.
Thirty five percent of 214 drug therapy interventions
had been solved with the adjustment of medication regimens
to elderly patients’ daily routine. Other 65% required
physician decision and the co-operative working between the
research pharmacist, the prescribers and patients. This
interaction was a key factor to solve and prevent the DTP in
PHCU. Thus, the physicians agreed to change 86% of drug
therapy regimen. By the end of the study, the interventions
solved 69% of actual DTP and prevented 78.5% potential
DTP. The results demonstrated an average of 4 ± 2
Pharmaceutical Care interviews to solve DTP.
All of the health education intervention that were
made were accepted by the patients and implemented by
them. Other studies showed the positive results of
interventions, leading to the solution and prevention of
DTP, reduction of treatment costs and satisfaction with
Pharmaceutical Care program (Lee et al., 2006; Lyra Jr. et
al., 2005; Vivian, 2002, Bernsten et al., 2001).
Some actual and potential DTP remained unresolved
or were not prevented. The resolution and prevention of
these DTP required modifications in drug regimens that
depended exclusively on a medical decision.
Reduction of weight response
At the baseline, 15 (50%) of the elderly presented
overweight and 7 (23%) obesity. The category of
overweight and obesity was defined as a BMI of 25 kg/m2
or greater. According to Ahrens et al. (2003), pharmacists
can play a role in helping patients to manage their weight
and decreasing the BP levels. After the interventions, the
patients showed a reduction of 27% in weight (defined as
weight loss greater than 7%), but did not observe a
significant difference in BMI results (Table I).
Others studies showed no statistically significant
differences (p<0,05) of BMI after pharmacist interventions
(Castro et al., 2006; Garção, Cabrita, 2002). People,
especially the elderly, have difficulty losing weight and
maintaining weight loss (Ahrens et al., 2003). The elevated
dropout rate suggests a need for other intervention
strategies to motivate patients to reduce and maintain their
weight loss.
Ahrens et al. (2003) suggested that to improve these
results it is necessary to have a lengthier intervention
period, training for the pharmacists and the interaction with
other health professionals (e.g., physicians and dietitians).
Thus, patients with obesity I and II that did not lose weight
during this study were referred to physicians and dietitians
at PHCU.
Blood pressure response
According to Blenkinsopp et al. (2000) the core of
the intervention lies in its potential to empower patients to
disclose their own concerns and questions about treatment.
Empowerment terms implies the ability to take thoughtful
action on one’s own behalf (Freire, 1983). In this study,
interventions such as in increasing the awareness of the
importance of BP control were effective in reducing
hypertension (Table II).
After empowerment, patients had significant mean
reductions from the baseline in systolic (18 mmHg) and
diastolic (12 mmHg) pressures (p<0.01). One meta-
analysis of 30 clinical trials concluded that 5 mmHg
reduction in SBP lowered the risk of cardiovascular events
and stroke by 25% to 30% (Staessen et al., 2003).
Reduction in DBP of 5 mmHg is associated with 34% less
strokes and 21% less coronary heart disease (Piechowski-
Józwiak, Bogousslavsky, 2006).
TABLE II – Changes in Blood Pressure (BP) of patients
between baseline and after Pharmaceutical Care
interventions, in PHCU Dr. Ítalo Baruffi (Ribeirão Preto –
SP), August 2003 to July 2004
Baseline After
BP Mean ± SD Mean ± SD p Value
(mmHg) (mmHg)
Systolic 146 ± 19,5 128 ± 17 0.0001
Diastolic 86.5 ± 16 74.5 ± 13 0.0001
TABLE I – Body Mass Index (BMI) of elderly outpatients,
at PHCU Dr. Ítalo Baruffi (Ribeirão Preto – SP), August
2003 to July 2004
BMI Baseline, f(%) After, f(%)
Underweight (< 18.5) 0 (0) 0 (0)
Normal weight (18.5 a 25) 8 (27) 9 (30)
Overweight (25 a 29.9) 15 (50) 13 (43.5)
Obese I (30 a 34.9) 5 (17) 7 (23.5)
Obese II (30 a 34.9) 2 (6) 1 (3)
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At the beginning of the study, only 5 of the patients
showed BP control (BP< 120/80 mmHg), and after the
Pharmaceutical Care intervention 13 (43.5%) attained a BP
below 120/80 mm Hg. At the end of the study, it was also
observed that another 13 (43.5%) of the patients achieved
improvement (e•5 mm Hg) without the BP control, 2
(6.5%) remained stable, and only 2 (6.5%) worsened. Thus,
there was an increase of 26.5% in the control of BP in the
elderly group.
These findings are better than in other studies that
reported the positive influence of pharmacists on outpatient
BP control (Castro et al., 2006; Lee et al., 2006; Garção,
Cabrita, 2002). This study is also consistent with three
other studies that obtained the same reduction in BP values
(Vivian, 2002; Mehos; Saseen; Mac Laughlin, 2000).
Furthermore, it is important to highlight that 13 (43.5%) of
the hypertensive patients also had diabetes and JNC-VII
(2003) guidelines recommend a pressure of <130/85 mm
Hg for these patients. Patients with diabetes and
hypertension are four times more likely to have a
cardiovascular event than patients without diabetes
(George et al., 2001).
This study had several limitations as follows:
researcher experience and education in Pharmaceutical
Care, number of patients (convenience sample), and
program conducted in only one setting. The Brazilian
pharmacists’ lack of experience in Pharmaceutical Care
may have prevented the detection of more DTP that
increase patient BP (Oliveira et al., 2005). Therefore, a
longer training period for the researcher might have
produced better results.
Because the population was small, it lacks statistical
power to detect a more significant difference in baseline and
follow-up BP in patients. Thus, to generalize the results,
larger size samples would be needed.
Subjects were recruited from one PCHU, so
extrapolating our results to other clinic settings and patient
populations may be limited. Furthermore, recruitment and
participation of patients was voluntary. Hence, it is possible
that patients who did not participate were systematically
different from those patients who participated.
CONCLUSIONS
The results demonstrate that although the
Pharmaceutical Care program did not observe a significant
difference in BMI results after 12 months, the BP control
improved in 87% of the patients. Based on these findings,
this study concludes that Pharmaceutical Care intervention
can be an effective method in improving BP control in
elderly outpatients, reducing the risk that hypertension
represents for cardiovascular disease. Heightened
awareness of the disease as well as increased pharmacist-
patient and physician interaction may facilitate drug
therapy modifications that are necessary to achieve desired
BP goals.
After this study, the researcher gave training about
practice of Pharmaceutical Care to 38 dispensing
pharmacists from the Public Health-System of Ribeirão
Preto. Nowadays, these pharmacists are perpetuating the
practice introduced in the region.
Finally, this study provides framework for the future
development of other outcomes studies in Brazilian
ambulatory care patients.
RESUMO
Efeito de intervenções de atenção farmacêutica na
pressão arterial de pacientes idosos com hipertensão
O objetivo deste estudo foi avaliar o efeito das intervenções
farmacêuticas na prevenção e solução de problemas rela-
cionados à farmacoterapia, ao índice de massa corporal e
ao controle da pressão arterial de um grupo de pacientes
idosos portadores de hipertensão arterial. O grupo de 30
pacientes assistidos na farmácia de uma unidade básica de
saúde, em Ribeirão Preto (SP), Brasil, foi acompanhado
por 12 meses. No estudo foi observado que as intervenções
do programa de Atenção Farmacêutica otimizaram o uso
dos medicamentos, reduziram os problemas de saúde cau-
sados pelos medicamentos e melhoraram as condições de
saúde dos pacientes. As intervenções influenciaram tanto
no cuidado prestado aos idosos como na obtenção de resul-
tados de saúde positivos. Depois deste estudo, o pesquisa-
dor ministrou um curso de capacitação sobre a prática da
Atenção Farmacêutica para 38 farmacêuticos da Secreta-
ria Municipal de Saúde de Ribeirão Preto (SP). Atualmente,
alguns destes farmacêuticos estão perpetuando a prática
introduzida na região.
UNITERMOS: Hipertensão Arterial. Idosos. Atenção
Farmacêutica.
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